Document:

Addendum to Employment Offer Letter

 Exhibit 10.97 
 Addendum To Employment Offer Letter 
 For Severance Benefits 
 The provisions of this Employment Offer Letter Addendum for Severance Benefits (the “Addendum”) are incorporated into, and are made a
part of, that employment offer letter (the “Offer Letter”) by and between you, Gregory Wrenn, and Borland Software Corporation (“Borland”). Capitalized terms used in this Addendum are either defined herein or in Appendix
A. 
 1. Severance Benefits. 
 (a) Termination of Employment Outside of the Change in Control Period. If your employment is terminated as a result of an Involuntary Termination other than during the Change in Control Period and you sign a release of claims (in a
form satisfactory to Borland, an example of which is attached hereto as Appendix B), then you shall be entitled to payment of fifty percent (50%) of your annual Base Salary, less applicable withholding. Such amount shall be payable in a lump
sum no later than five (5) days following expiration of any revocation period required in connection with the release of claims; provided, however, if this payment is subject to Section 409A and you are a “specified employee” (as
defined in Section 409A), this payment shall be made within five (5) days after the six (6) month anniversary of the Termination Date (or such sooner date that is permitted under Section 409A). 
 (b) Termination of Employment During the Change in Control Period. If your employment is terminated as a result of an Involuntary Termination
during the Change in Control Period and you sign a release of claims (substantially in the form attached hereto as Appendix B), then you shall be entitled to payment of one hundred percent (100%) of your annual Base Salary, less applicable
withholding. Such amount shall be payable in a lump sum no later than five (5) days following expiration of any revocation period required in connection with the release of claims; provided, however, if this payment is subject to
Section 409A and you are a “specified employee” (as defined in Section 409A), this payment shall be made within five (5) days after the six (6) month anniversary of the Termination Date (or such sooner date that is
permitted under Section 409A). 
 (c) Continuing Medical Coverage. If your employment is terminated as a result of an Involuntary
Termination, whether or not a Change in Control Period, and you sign a release of claims (in a form satisfactory to Borland, an example of which is attached hereto as Appendix B), then you shall be entitled to payment for your premiums for health
(i.e., medical, vision and dental) continuation coverage under COBRA; provided, however, that (i) you are eligible for COBRA on the Termination Date and (ii) you elect continuation coverage pursuant to COBRA, within the required time
period. Borland shall continue to provide you with health coverage pursuant to this paragraph until the earliest of (i) the date you are no longer eligible to receive continuation coverage pursuant to COBRA, (ii) twelve (12) months
from the Termination Date or (iii) the date on which you obtain comparable health coverage. You agree to notify Borland promptly after you obtain alternative health coverage. 
 2. Mitigation. Except as otherwise specifically provided herein, you shall not be required to mitigate damages or the amount of any payment
provided under this Addendum by seeking other employment or otherwise, nor shall the amount of any payment provided for under this Addendum be reduced by any compensation you earn as a result of your employment by another employer or by any
retirement benefits you receive after the Termination Date. 
 3. Successors. 
 (a) Borland’s Successors. Any successor to Borland (whether direct or indirect and whether by purchase, lease, merger, consolidation,
liquidation or otherwise) to all or substantially all of Borland’s business and/or assets shall assume Borland’s obligations under this Addendum and agree expressly to perform Borland’s obligations under this Addendum in the same
manner and to the same extent as Borland would be required to perform such obligations in the absence of a succession. For all purposes under this Addendum, the term “Borland” shall include any successor to Borland’s business and/or
assets which acknowledges it will be bound by the terms of this Addendum or which becomes bound by the terms of this Addendum by operation of law. 

 (b) Your Successors. Without the written consent of Borland, you shall not assign or transfer this
Addendum or any right or obligation under this Addendum to any other person or entity. Notwithstanding the foregoing, the terms of this Addendum and all you rights hereunder shall inure to the benefit of, and be enforceable by, your personal or
legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. 
 4. Notices. Notices and
all other communications contemplated by this Addendum shall be in writing and shall be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In
your case, mailed notices shall be addressed to you at the home address which you most recently communicated to Borland in writing. In the case of Borland, mailed notices shall be addressed to its corporate headquarters, and all notices shall be
directed to the attention of its General Counsel. 
 5. Code Section 409A. The parties agree to amend this Addendum to the
extent necessary to avoid imposition of any additional tax or income recognition prior to actual payment to you under Code Section 409A and any temporary or final Treasury Regulations and Internal Revenue Service guidance thereunder.

 6. Miscellaneous Provisions. 
 (a) Integration. This Addendum represents the entire agreement and understanding between the parties as to the subject matter herein and supersede all prior or contemporaneous agreements and provisions in other agreements related to
severance benefits, whether written or oral. With respect to any conflict between this Addendum and any stock option agreement, stock issuance agreement or other stock award agreement, this Addendum shall prevail. With respect to any conflict
between this Addendum and the Offer Letter or any other employment related agreement, this Addendum shall prevail. For the avoidance of doubt, with respect to any severance benefits provided for under your Offer Letter, this Addendum shall supersede
the provisions of your Offer Letter with respect to severance benefits provided thereunder. 
 (b) Choice of Law. The validity,
interpretation, construction and performance of this Addendum shall be governed by the internal substantive laws, but not the conflicts of law rules, of the State of California. 
 (c) Employment Taxes. All payments made pursuant to this Addendum shall be subject to withholding of applicable income and employment taxes.

 (d) Non-Publication. The parties mutually agree not to disclose the terms of this Addendum except to the extent that disclosure is
mandated by applicable law, standard or required corporate reporting, or disclosure is made to the parties’ respective advisors and agents (e.g., attorneys, accountants) or immediate family members. 
 IN WITNESS WHEREOF, each of the parties has executed this Addendum, in the case of Borland by its duly authorized officer, as of the day and year first
above written. 
  

							
	 BORLAND SOFTWARE CORPORATION:
	 	EXECUTIVE:
		
	 /s/ Tod Nielsen
	 	 /s/ Gregory Wrenn

				
		  	 (Signature)
	 		 	 (Signature)

				
	 By:
	  	 Tod Nielsen
	 	 By:
	 	 Gregory Wrenn 

	 Title:
	  	 President and Chief Executive Officer
	 	 Title:
	 	 Senior VP and General Counsel

 APPENDIX A 
 The following definitions shall be in effect under the severance benefits letter: 
 (a) Base Salary. “Base Salary” means your annual base salary as in effect during the last regularly scheduled payroll period immediately
preceding the effective date of your termination due to an Involuntary Termination. 
 (b) Board. “Board” means the Board of
Directors of Borland. 
 (c) Change in Control. “Change in Control” means a change in ownership or control of the Company
effected through any of the following transactions: 
 (i) there is consummated a merger, consolidation or other reorganization, unless
securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same
proportion, by the persons who beneficially owned the Corporation’s outstanding voting securities immediately prior to such transaction, or 
 (ii) the sale, transfer or other disposition of all or substantially all of the Corporation’s assets in complete liquidation or dissolution of the Corporation other than a sale or disposition by the Corporation of all or substantially
all of the Corporation’s assets to an entity, at least fifty percent (50%) of the combined voting power of the voting securities of which are owned by stockholders of the Corporation in substantially the same proportions as their ownership
of the Corporation immediately prior to such sale, or 
 (iii) the acquisition, directly or indirectly, by any person or related group of
persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation) of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities
possessing more than thirty percent (30%) of the total combined voting power of the Corporation’s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation’s stockholders. 
 Notwithstanding the foregoing, a “Change in Control” shall not be deemed to have occurred by virtue of the consummation of any transaction or
series of integrated transactions immediately following which the record holders of the Common Stock immediately prior to such transaction or series of transactions continue to have substantially the same proportionate ownership in an entity which
owns all or substantially all of the assets of the Corporation immediately following such transaction or series of transactions. 
 (d)
Change in Control Period. “Change in Control Period” means the period beginning either (i) two (2) months prior to the effective date of a Change in Control and ending twelve (12) months after the effective date of a
Change in Control or (ii) two (2) months prior to the effective date of a Hostile Takeover and ending twelve (12) months after the effective date of a Hostile Takeover. 
 (e) COBRA. “COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended. 
 (f) Code. “Code” means the Internal Revenue Code of 1986, as amended. 
 (g) Constructively Terminated. “Constructively Terminated” means your voluntary resignation following (A) a change in your position
with the Company (or any Parent or Subsidiary employing you) which materially reduces your duties and responsibilities, (B) a reduction in your level of compensation (including base salary, fringe benefits and target bonus under any corporate
performance based bonus or incentive programs) or (C) a relocation of your place of employment by more than fifty (50) miles, provided and only if such change, reduction or relocation is effected by the Corporation without your consent.

 (h) Hostile Take-Over. “Hostile Take-Over” shall be deemed to occur in the event
of a change in ownership or control of the Company effected through either of the following transactions: 
 (i) a change in the composition
of the Board such that the following individuals cease for any reason to constitute a majority of the Board then serving: individuals who, on the date hereof, constitute the members of the Board and any new Board member (other than a Board member
whose initial assumption of office is in connection with an actual or threatened election contest, including (but not limited to) a consent solicitation, relating to the election of Board members) whose appointment or election by the Board or
nomination for election by the Corporation’s stockholders was approved or recommended by a vote of at least two-thirds (2/3) of the Board members then still in office who either were Board members on the date hereof or whose appointment,
election or nomination for election was previously so approved or recommended, or 
 (ii) the acquisition, directly or indirectly, by any
person or related group of persons (other than Borland or a person that directly or indirectly controls, is controlled by, or is under common control with, Borland) of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of
securities possessing more than thirty percent (30%) of the total combined voting power of the Borland’s outstanding securities pursuant to a tender or exchange offer made directly to the Borland’s stockholders which the Board does
not recommend such stockholders to accept. 
 (i) Involuntary Termination. “Involuntary Termination” means any termination of
you by Borland which is not effected for Misconduct; (ii) any purported termination of you by Borland which is effected for Misconduct but for which the grounds relied upon are not valid; (iii) any voluntary termination by you as a result
of your being Constructively Terminated; or (iv) the failure of Borland to obtain the assumption of this Addendum by any successors contemplated in Section 4 of the Addendum. 
 (j) Misconduct. “Misconduct” means (i) your willful and continued failure to perform the duties and responsibilities of your
position that is not corrected within a thirty (30) day correction period that begins upon delivery to you of a written demand for performance from Borland that describes the basis for Borland’s belief that you have not substantially
performed your duties; (ii) any act of personal dishonesty taken by you in connection with your responsibilities as an employee of Borland with the intention that such may result in substantial personal enrichment for you; (iii) your
conviction of, or plea of nolo contendre to, a felony that Borland reasonably believes has had or will have a material detrimental effect on Borland’s reputation or business, or (iv) your materially breaching your Employee Confidentiality
and Assignment of Inventions Agreement, which breach is (if capable of cure) not cured within thirty (30) days after Borland delivers written notice to you of the breach. 
 (k) Section 409A. “Section 409A” shall mean Section 409A of the Code. 
 (l) Termination Date. “Termination Date” shall mean the effective date of any notice of termination delivered by one party to the other
hereunder. 

 APPENDIX B 
 RELEASE OF CLAIMS 
 I understand
that my employment with Borland Software Corporation (“Borland”) terminated effective
                            ,          (the
“Separation Date”). Borland has agreed that if I choose to sign this Release of Claims (“Release”), Borland will pay me certain severance benefits (minus standard withholdings and deductions) pursuant to the terms
of the Employment Offer Letter Addendum for Severance Benefits letter between myself and Borland, dated                  (the “Agreement”). I
understand that I am not entitled to such benefits unless I sign this Release and it becomes fully effective. I understand that, regardless of whether I sign this Release, Borland will pay me all of my accrued salary and vacation through the
Separation Date, to which I am entitled by law. 
 In consideration for the severance benefits I am receiving under the Agreement, as
described therein, I hereby generally and completely release Borland, its directors, officers, employees, stockholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns from any
and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to my signing this Agreement. This general release includes, but is not limited
to: (1) all claims arising out of or in any way related to my employment with Borland or the termination of that employment or the services I provided to Borland; (2) all claims related to my compensation or benefits from Borland,
including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock options, restricted stock awards, other equity compensation or any other ownership interests in Borland; (3) all claims for
breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and
(5) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with
Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (“ADEA”), and the California Fair Employment and Housing Act (as amended). Notwithstanding anything contained in this Release, nothing herein
shall release the parties’ rights under this Release and my right (if any) to indemnification granted by any act or agreement of Borland, state or federal law or policy of insurance or any claims for severance benefits under the Agreement.

 In releasing claims unknown to me at present, I am waiving all rights and benefits under Section 1542 of the California Civil Code,
and any law or legal principle of similar effect in any jurisdiction: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known
by him or her must have materially affected his or her settlement with the debtor.” 
 I understand this Release will not be
effective until the ADEA Effective Date, defined below. I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under the ADEA. I also acknowledge that the consideration given for the waiver in the above
paragraph is in addition to anything of value to which I was already entitled. I have been advised by this writing, as required by the ADEA that: (a) my waiver and release does not apply to any claims that may arise after my signing of this
Release; (b) I should consult with an attorney prior to signing this Release; (c) I have twenty-one (21) days within which to consider this Release (although I may choose to voluntarily sign this Release earlier); (d) I have
seven (7) days after I sign this Release to revoke it; and (e) this Release will not be effective until the eighth day after this Release has been signed by me (the “ADEA Effective Date”). 
 I accept and agree to the terms and conditions stated above: 
  

			
	  
	  	  

	 Date
	  	Gregory WrennSublease Termination Agreement

 Exhibit 10.78 
 SUBLEASE TERMINATION AGREEMENT 
 This Sublease Termination Agreement (the
“Agreement”) is made and entered into as of September 14, 2006 by and between Molecular Imaging Corporation, a Delaware corporation (“MIC”), and Siemens Medical Solutions USA, Inc., a Delaware corporation
(“Siemens”), with reference to the following facts: 
 A. BC Sorrento, LLC, a California limited liability company and
Siemens have entered into a master lease (the “Master Lease”) for certain premises located in that certain office building commonly known as 11388 Sorrento Valley Road, San Diego, California (the “Premises”), which
Premises are more particularly described in the Master Lease. 
 B. MIC and Siemens entered into a Agreement of Sub-Lease dated
February 24, 2006 (the “MIC Sublease”) for a portion of the Premises; 
 C. MIC, Molecular Imaging Sorrento Valley LLC,
a Delaware limited liability company (“PET LLC”), and The Regents of the University of California, a California corporation, (“UCSD”) have entered into an Asset Purchase Agreement dated September 2006 (the
“Asset Purchase Agreement”), pursuant to which PET LLC will transfer its operations at the Premises to UCSD; 
 D. Effective
upon the Closing, MIC desires to terminate the MIC Sublease, and Siemens agrees to terminate the MIC Sublease. 
 NOW, THEREFORE, for good
and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 
 1. Termination
of Sublease. Effective upon the Closing, the MIC Sublease shall be terminated, and other than any obligations of MIC to pay utilities and/or its pro-rata share of any operating costs under the MIC Sublease for the period of its occupancy before
termination, neither party shall have any future or historical obligations to one another under the MIC Sublease. 
 2. Mutual
Release. MIC and Siemens each releases and discharges the other party and its past and present employees, officers, agents, and attorneys from any and all liabilities, claims, loss, damages, defenses, fees and costs (including costs of suit and
attorneys’ fees and expenses) of whatever nature, character, type, or description, whether known or unknown, existing or potential, matured or unmatured, liquidated or unliquidated, direct or consequential, suspected or unsuspected, or foreseen
or unforeseen, asserted in or relating to the Sublease Agreement or Premises. The parties each acknowledge, warrant, and represent that they have been advised by their respective attorneys concerning, and that they are familiar with, section 1542 of
the California Civil Code (“Section 1542”), which provides: “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE  

  

 1 

 
RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.” In waiving the provisions of Section 1542, the
parties each acknowledge that they may have sustained damages, losses, costs, or expenses that presently are unknown and unsuspected, and that such damages, losses, costs, or expenses as may have been sustained may give rise to additional damages,
losses, costs, or expenses in the future. The parties further acknowledge that they have negotiated this Agreement taking into account such presently unsuspected and unknown damages, losses, costs, and expenses, and the parties expressly waive any
and all rights that they have under Section 1542 or under any other state or federal statute, rule, or common law principle, in law or in equity, of similar effect. 
 3. Effective Date. This Agreement shall become effective upon, and only in the event of, the Closing under the Asset Purchase Agreement. 
 IN WITNESS WHEREOF, the parties hereto have executed this Sublease Termination Agreement the day and year first above written. 
  

									
	MIC:	 		 	SIEMENS:
			
	 Molecular Imaging Corporation
	 		 	 Siemens Medical Solutions USA, Inc.

					
	By:	 	 /s/ Kenneth C. Frederick
	 		 	 By:
	 	 /s/ Michael Reitermann

		 	 Kenneth C. Frederick, CEO
	 		 		 	 Michael Reitermann

		 		 		 		 	 President, Molecular Imaging

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}]]